Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Ранг среди акций #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Цена акции
$240.45
Рыночная капитализация
$579.46B
Изменение (1 день)
0.51%
Изменение (1 год)
46.88%
Страна
US
Торговля Johnson & Johnson (JNJ)

Категория

Прибыль Johnson & Johnson (JNJ)
Прибыль на Dec 2025 TTM: $32.58B
Согласно последним финансовым отчетам Johnson & Johnson, текущая прибыль компании составляет $32.58B. В 2024 году компания получила прибыль $16.69B, больше, чем прибыли за 2023, которая составила $15.06B. Отображаемая прибыль на этой странице — это прибыль до уплаты процентов и налогов, или просто EBIT.
История прибыли компании Johnson & Johnson с 2000 по 2026
Прибыль в конце каждого года
Год Прибыль Изменить
2026 (TTM) $32.58B 0.00%
2025 $32.58B 95.25%
2024 $16.69B 10.79%
2023 $15.06B -21.46%
2022 $19.18B 16.25%
2021 $16.50B -4.80%
2019 $17.33B -3.73%
2018 $18.00B 1.84%
2017 $17.67B -10.76%
2016 $19.80B 3.16%
2015 $19.20B -6.65%
2014 $20.56B 32.91%
2013 $15.47B 12.31%
2012 $13.78B 11.44%
2011 $12.36B -27.06%
2010 $16.95B 7.57%
2009 $15.76B -6.93%
2008 $16.93B 27.45%
2007 $13.28B -8.94%
2006 $14.59B 11.22%
2005 $13.12B 6.37%
2004 $12.33B 19.63%
2003 $10.31B 10.95%
2002 $9.29B 17.64%
2001 $7.90B 15.00%
2000 $6.87B 0.00%
Прибыль схожих компаний или конкурентов
Компания Прибыль Разница в прибыли Страна
$25.73B -21.03%
US
$6.60B -79.75%
US
$16.35B -49.81%
CH
$12.40B -61.93%
GB
$21.07B -35.34%
US